Skingenix, Inc.   Report issue

For profit Phase 2
Founded: Arcadia CA United States (2001)

Organization Overview

First Clinical Trial
2010
NCT01138436
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now